Persistence: Mechanisms for triggering and enhancing phenotypic variability

Current Opinion in Genetics and Development

Volumn 21, Issue 6, 2011, Pages 768-775

  Balaban, N Q ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITOXIN; TOXIN;

BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL GROWTH; BIOFILM; CANDIDA ALBICANS; DNA REPLICATION; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FEEDBACK SYSTEM; GENETIC VARIABILITY; GROWTH INHIBITION; HIP GENE; HOST PATHOGEN INTERACTION; MICROBIAL GENETICS; MICROBIAL POPULATION DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MYCOBACTERIUM; NONHUMAN; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA;

ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; ANTITOXINS; BACTERIA; BACTERIAL TOXINS; CELL DIVISION; CELL SURVIVAL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VARIATION; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 81955167411     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2011.10.001     Document Type: Review

References (72)

1. Bigger J.W. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 1944, 244:497-500.
2. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007, 5:48-56.
3. Dhar N., McKinney J.D. Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol 2007, 10:30-38.
4. Shleeva M.O., Salina E.G., Kaprelyants A.S. Dormant forms of mycobacteria. Microbiology 2010, 79:1-12.
5. Chick H. The process of disinfection by chemical agencies and hot water. J Hygiene 1910, 10:237-286.
6. Cerf O. Tailing of survival curves of bacterial-spores. J Appl Bacteriol 1977, 42:1-19.
7. Gefen O., Balaban N.Q. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev 2009, 33:704-717.
8. Levin B.R., Udekwu K.I. Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments. Antimicrob Agents Chemother 2010, 54:3414-3426.
9. Pearl S., Gabay C., Kishony R., Oppenheim A., Balaban N.Q. Nongenetic individuality in the host-phage interaction. PLoS Biol 2008, 6:e120.
10. Kussell E., Kishony R., Balaban N.Q., Leibler S. Bacterial persistence: a model of survival in changing environments. Genetics 2005, 169:1807-1814.
11. Allison K.R., Brynildsen M.P., Collins J.J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011, 473:216-220.
12. Kim J.S., Heo P., Yang T.J., Lee K.S., Cho D.H., Kim B.T., Suh J.H., Lim H.J., Shin D., Kim S.K., et al. Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother 2011, 55:5380-5383.
13. Yeger-Lotem E., Sattath S., Kashtan N., Itzkovitz S., Milo R., Pinter R.Y., Alon U., Margalit H. Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. Proc Natl Acad Sci U S A 2004, 101:5934-5939.
14. Keren I., Kaldalu N., Spoering A., Wang Y., Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004, 230:13-18.
15. Balaban N.Q., Merrin J., Chait R., Kowalik L., Leibler S. Bacterial persistence as a phenotypic switch. Science 2004, 305:1622-1625.
16. Levin-Reisman I., Gefen O., Fridman O., Ronin I., Shwa D., Sheftel H., Balaban N.Q. Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes. Nat Methods 2010, 7:737-739.
17. Tuomanen E., Cozens R., Tosch W., Zak O., Tomasz A. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol 1986, 132:1297-1304.
18. Eng R.H., Padberg F.T., Smith S.M., Tan E.N., Cherubin C.E. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother 1991, 35:1824-1828.
19. Moyed H.S., Bertrand K.P. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 1983, 155:768-775.
20. Gefen O., Gabay C., Mumcuoglu M., Engel G., Balaban N.Q. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A 2008, 105:6145-6149.
21. Guillier L., Pardon P., Augustin J.C. Automated image analysis of bacterial colony growth as a tool to study individual lag time distributions of immobilized cells. J Microbiol Methods 2006, 65:324-334.
22. Luidalepp H., Joers A., Kaldalu N., Tenson T. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J Bacteriol 2011, 193:3598-3605.
23. Fung D.K.C., Chan E.W.C., Chin M.L., Chan R.C.Y. Delineation of a bacterial starvation stress response network which can mediate antibiotic tolerance development. Antimicrob Agents Chemother 2010, 54:1082-1093.
24. Baek S.H., Li A.H., Sassetti C.M. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol 2011, 9:e1001065.
25. Korch S.B., Henderson T.A., Hill T.M. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 2003, 50:1199-1213.
26. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Moscow) 2005, 70:267-274.
27. LaFleur M.D., Kumamoto C.A., Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006, 50:3839-3846.
28. Al-Dhaheri R.S., Douglas L.J. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother 2008, 52:1884-1887.
29. Kayama S., Murakami K., Ono T., Ushimaru M., Yamamoto A., Hirota K., Miyake Y. The role of rpoS gene and quorum-sensing system in ofloxacin tolerance in Pseudomonas aeruginosa. FEMS Microbiol Lett 2009, 298:184-192.
30. Moker N., Dean C.R., Tao J. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 2010, 192:1946.
31. Helaine S., Thompson J.A., Watson K.G., Liu M., Boyle C., Holden D.W. Dynamics of intracellular bacterial replication at the single cell level. Proc Natl Acad Sci U S A 2010, 107:3746-3751.
32. Doerr T., Vulic M., Lewis K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 2010, 8.
33. Debbia E.A., Roveta S., Schito A.M., Gualco L., Marchese A. Antibiotic persistence: the role of spontaneous DNA repair response. Microb Drug Resist 2001, 7:335-342.
34. Booth I.R. Stress and the single cell: intrapopulation diversity is a mechanism to ensure survival upon exposure to stress. Int J Food Microbiol 2002, 78:19-30.
35. Tuchscherr L., Medina E., Hussain M., Volker W., Heitmann V., Niemann S., Holzinger D., Roth J., Proctor R.A., Becker K., et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 2011, 3:129-141.
36. Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 2004, 9:1136-1156.
37. Adams K.N., Takaki K., Connolly L.E., Wiedenhoft H., Winglee K., Humbert O., Edelstein P.H., Cosma C.L., Ramakrishnan L. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 2011, 145:39-53.
38. Dhar N., McKinney J.D. Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice. Proc Natl Acad Sci U S A 2010, 107:12275-12280.
39. Cara S., Tannock I.F. Retreatment of patients with the same chemotherapy: implications for clinical mechanisms of drug resistance. Ann Oncol 2001, 12:23.
40. Brock A., Chang H., Huang S. OPINION non-genetic heterogeneity-a mutation-independent driving force for the somatic evolution of tumours. Nat Rev Genet 2009, 10:336-342.
41. Sharma S.V., Lee D.Y., Li B., Quinlan M.P., Takahashi F., Maheswaran S., McDermott U., Azizian N., Zou L., Fischbach M.A., et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
42. Al-Dhaheri R.S., Douglas L.J. Apoptosis in Candida biofilms exposed to amphotericin B. J Med Microbiol 2010, 59:149-157.
43. Fauvart M., De Groote V.N., Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol 2011, 60:699-709.
44. Balaban N.Q. Persister Bacteria. Bacterial Stress Responses 2011, 375-382. ASM Press. edn 2. G. Storz, R. Hengge (Eds.).
45. Elowitz M.B., Levine A.J., Siggia E.D., Swain P.S. Stochastic gene expression in a single cell. Science 2002, 297:1183-1186.
46. Ozbudak E.M., Thattai M., Lim H.N., Shraiman B.I., van Oudenaarden A. Multistability in the lactose utilization network of Escherichia coli. Nature 2004, 427:737-740.
47. Eldar A., Elowitz M.B. Functional roles for noise in genetic circuits. Nature 2010, 467:167-173.
48. Black D.S., Kelly A.J., Mardis M.J., Moyed H.S. Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA-synthesis. J Bacteriol 1991, 173:5732-5739.
49. Gerdes K., Christensen S.K., Lobner-Olesen A. Prokaryotic toxin-antitoxin stress response loci. Nat Rev Microbiol 2005, 3:371-382.
50. Rotem E., Loinger A., Ronin I., Levin-Reisman I., Gabay C., Shoresh N., Biham O., Balaban N.Q. Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci U S A 2010, 107:12541-12546.
51. Klumpp S., Zhang Z.G., Hwa T. Growth rate-dependent global effects on gene expression in bacteria. Cell 2009, 139:1366-1375.
52. Lou C., Li Z., Ouyang Q. A molecular model for persister in E. coli. J Theor Biol 2008, 255:205-209.
53. Harrison J.J., Wade W.D., Akierman S., Vacchi-Suzzi C., Stremick C.A., Turner R.J., Ceri H. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob Agents Chemother 2009, 53:2253-2258.
54. Wang X., Wood T.K. Toxin/antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol 2011, 77:5577-5583.
55. Kim Y., Wood T.K. Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem Biophys Res Commun 2010, 391:209-213.
56. Kolodkin-Gal I., Verdiger R., Shlosberg-Fedida A., Engelberg-Kulka H. A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation. PLoS ONE 2009, 4:e6785.
57. Sureka K., Ghosh B., Dasgupta A., Basu J., Kundu M., Bose I. Positive feedback and noise activate the stringent response regulator rel in mycobacteria. PLoS ONE 2008, 3:e1771.
58. Ghosh S., Sureka K., Ghosh B., Bose I., Basu J., Kundu M. Phenotypic heterogeneity in mycobacterial stringent response. BMC Syst Biol 2011, 5:18.
59. Tan C., Marguet P., You L. Emergent bistability by a growth-modulating positive feedback circuit. Nat Chem Biol 2009, 5:842-848.
60. Johnston R.J., Desplan C. Stochastic mechanisms of cell fate specification that yield random or robust outcomes. Annu Rev Cell Dev Biol 2010, 26:689-719.
61. Igoshin O.A., Price C.W., Savageau M.A. Signalling network with a bistable hysteretic switch controls developmental activation of the sigma transcription factor in Bacillus subtilis. Mol Microbiol 2006, 61:165-184.
62. Carniol K., Eichenberger P., Losick R. A threshold mechanism governing activation of the developmental regulatory protein sigma F in Bacillus subtilis. J Biol Chem 2004, 279:14860-14870.
63. Chung J.D., Stephanopoulos G., Ireton K., Grossman A.D. Gene expression in single cells of Bacillus subtilis: evidence that a threshold mechanism controls the initiation of sporulation. J Bacteriol 1994, 176:1977-1984.
64. Chastanet A., Vitkup D., Yuan G.C., Norman T.M., Liu J.S., Losick R.M. Broadly heterogeneous activation of the master regulator for sporulation in Bacillus subtilis. Proc Natl Acad Sci U S A 2010, 107:8486-8491.
65. Ramage H.R., Connolly L.E., Cox J.S. Comprehensive functional analysis of mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet 2009, 5.
66. Van Melderen L., Saavedra De Bast M. Bacterial toxin-antitoxin systems: more than selfish entities?. PLoS Genet 2009, 5:e1000437.
67. Maisonneuve E., Shakespeare L.J., Jorgensen M.G., Gerdes K. Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci 2011, 108:13206-13211.
68. Mulcahy L.R., Burns J.L., Lory S., Lewis K. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 2010, 192:6191-6199.
69. Kussell E., Leibler S. Phenotypic diversity, population growth, and information in fluctuating environments. Science 2005, 309:2075-2078.
70. Keren I., Shah D., Spoering A., Kaldalu N., Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 2004, 186:8172-8180.
71. Korch S.B., Hill T.M. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol 2006, 188:3826-3836.
72. Shleeva M., Mukamolova G.V., Young M., Williams H.D., Kaprelyants A.S. Formation of 'non-culturable' cells of Mycobacterium smegmatis in stationary phase in response to growth under suboptimal conditions and their Rpf-mediated resuscitation. Microbiology 2004, 150:1687-1697.